0001062993-22-014841.txt : 20220615 0001062993-22-014841.hdr.sgml : 20220615 20220614174347 ACCESSION NUMBER: 0001062993-22-014841 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220614 EFFECTIVENESS DATE: 20220615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mydecine Innovations Group Inc. CENTRAL INDEX KEY: 0001841626 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-449213 FILM NUMBER: 221015992 BUSINESS ADDRESS: STREET 1: 789 W. PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1H2 BUSINESS PHONE: 6479855478 MAIL ADDRESS: STREET 1: 789 W. PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1H2 D 1 primary_doc.xml X0708 D LIVE 0001841626 Mydecine Innovations Group Inc. 810 - 789 W. PENDER STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 1H2 604-687-2038 BRITISH COLUMBIA, CANADA New Age Farm Inc. NewLeaf Brands Inc. New Age Brands Inc. None Corporation true Joshua Bartch 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Director Dean Ditto 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Damon Michaels 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Director Robert Roscow 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Director Sanford Stein 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Dr. Rakesh Jetly 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Executive Officer Dr. Saeid Babaei 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Director Gordon Neal 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Director Josephine Wu 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Director Dr. Victoria Hale 810 - 789 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1H2 Director Other Decline to Disclose 06b false 2022-05-27 false true true true true Each Unit consists of 1 cm sh & 1 cm sh purchase wrt. Each whole wrt entitles the holder to purchase 1 cm sh at a price of CDN$1.40 for a period of 5 years following the closing date. false 0 1392695 628078 764617 "Total Remaining to be Sold" is the aggregate purchase price of shares underlying warrants sold in this offering. U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7851 reported on May 27, 2022. false 1 0 0 0 false Mydecine Innovations Group Inc. /s/ Joshua Bartch Joshua Bartch Chief Executive Officer & Director 2022-06-14